Evolving outcomes of extracorporeal membrane oxygenation during the first 2 years of the COVID-19 pandemic: a systematic review and meta-analysis

Ryan Ruiyang Ling,Kollengode Ramanathan,Jackie Jia Lin Sim,Suei Nee Wong,Ying Chen,Faizan Amin,Shannon M. Fernando,Bram Rochwerg,Eddy Fan,Ryan P. Barbaro,Graeme MacLaren,Kiran Shekar and Daniel Brodie

DOI: https://doi.org/10.1186/s13054-022-04011-2

IF: 15.1

2022-05-24

Critical Care

Abstract:Extracorporeal membrane oxygenation (ECMO) has been used extensively for coronavirus disease 2019 (COVID-19)-related acute respiratory distress syndrome (ARDS). Reports early in the pandemic suggested that mortality in patients with COVID-19 receiving ECMO was comparable to non-COVID-19-related ARDS. However, subsequent reports suggested that mortality appeared to be increasing over time. Therefore, we conducted an updated systematic review and meta-analysis, to characterise changes in mortality over time and elucidate risk factors for poor outcomes.

critical care medicine